Clearside Biomedical, Inc. (CLSD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -5.48M | -4.73M | -5.83M | -5.25M | -5.91M | -5.68M | -7.85M | 495K | -6.08M | -5.34M | -7.22M | -5.61M |
| Operating CF Margin % | -2726.37% | -961.18% | -250.21% | -1716.99% | -569.65% | -6311.11% | -3413.48% | 7.8% | -707.22% | -524.46% | -180400% | -1699.09% |
| Operating CF Growth % | 7.32% | 16.74% | 25.74% | -1161.41% | 2.67% | -6.39% | -8.8% | 108.83% | 1.79% | 1.91% | -286.41% | -210.94% |
| Net Income | -5.97M | -4.5M | -8.22M | -7.31M | -7.69M | -7.59M | -11.76M | -4.83M | -9.27M | -9.11M | -9.28M | -9.66M |
| Depreciation & Amortization | 84K | 84K | 85K | 79K | 75K | 44K | 28K | 20K | 16K | 16K | 15K | 22K |
| Stock-Based Compensation | 746K | 694K | 721K | 1.17M | 1.17M | 1.12M | 1.06M | 1.03M | 1.07M | 1.06M | 1.04M | 1.15M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -419K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1M | 1.04M | 2.47M | 461K | 1.92M | 313K | 3.9M | 2.7M | 2.62M | 2.29M | 2.17M | 2.02M |
| Working Capital Changes | 665K | -2.05M | -879K | 346K | -1.38M | 437K | -1.08M | 2M | -520K | 396K | -1.16M | 865K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.42K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -280K | -1.97M | 215K | -310K | -32K | 0 | -1.11M | 647K | 752K | 282K | 0 | 694K |
| Cash from Investing | 0 | 0 | -9K | 9.31M | 1.55M | -11.44M | -57K | -120K | -445K | -1.1M | -115K | -91K |
| Capital Expenditures | 0 | 0 | -9K | -444K | -53K | -423K | -57K | -120K | -445K | -1.1M | -115K | -91K |
| CapEx % of Revenue | - | - | 0.39% | 145.1% | 5.11% | 470% | 24.78% | 1.89% | 51.8% | 107.76% | 2875% | 27.58% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -11.01M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.9M | 477K | -553K | 2.08M | 14K | 0 | 14.34M | -257K | 317K | 22K | 332K | 575K |
| Debt Issued (Net) | 0 | 977K | 434K | -450K | 0 | 0 | 450K | -923K | 266K | 0 | 0 | 0 |
| Equity Issued (Net) | 10K | 977K | 13K | 2.53M | 14K | 0 | 14.31M | 743K | 266K | 362K | 295K | 575K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 2.9M | -1.48M | -1M | 0 | 0 | 0 | -417K | -77K | -215K | -340K | 37K | 0 |
| Net Change in Cash | -2.58M | -4.25M | -6.39M | 6.13M | -4.35M | -17.12M | 6.43M | 118K | -6.2M | -6.41M | -7M | -5.12M |
| Free Cash Flow | -5.48M | -4.73M | -5.83M | -5.7M | -5.97M | -6.1M | -7.91M | 375K | -6.52M | -6.44M | -7.33M | -5.7M |
| FCF Margin % | -2726.37% | -961.18% | -250.21% | -1862.09% | -574.76% | -6781.11% | -3438.26% | 5.91% | -759.02% | -632.22% | -183275% | -1726.67% |
| FCF Growth % | 8.15% | 22.51% | 26.28% | -1619.47% | 8.5% | 5.17% | -7.87% | 106.58% | -2.82% | -18.24% | -289.38% | -212.74% |
| FCF per Share | -1.05 | -0.91 | -1.14 | -1.13 | -1.20 | -1.22 | -1.70 | 0.09 | -1.58 | -1.57 | -1.80 | -1.41 |
| FCF Conversion (FCF/Net Income) | 0.92x | 1.05x | 0.71x | 0.72x | 0.77x | 0.75x | 0.67x | -0.10x | 0.66x | 0.59x | 0.78x | 0.58x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |